BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33908609)

  • 1. Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors.
    Cui Y; Li C; Jiang Z; Zhang S; Li Q; Liu X; Zhou Y; Li R; Wei L; Li L; Zhang Q; Wen L; Tang F; Zhou D
    Neuro Oncol; 2021 Nov; 23(11):1859-1871. PubMed ID: 33908609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
    Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pangenomic Classification of Pituitary Neuroendocrine Tumors.
    Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G
    Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
    Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
    Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.
    Rymuza J; Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Nyc A; Baluszek S; Zieliński G; Kunicki J; Bujko M
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
    Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
    Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors.
    Yan N; Xie W; Wang D; Fang Q; Guo J; Chen Y; Li X; Gong L; Wang J; Guo W; Zhang X; Zhang Y; Gu J; Li C
    Genome Med; 2024 Jan; 16(1):2. PubMed ID: 38167466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
    Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
    Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT.
    Yao H; Xie W; Dai Y; Liu Y; Gu W; Li J; Wu L; Xie J; Rui W; Ren B; Xue L; Cheng Y; Lin S; Li C; Tang H; Wang Y; Lou M; Zhang X; Hu R; Shang H; Huang J; Wu ZB
    Neuro Oncol; 2022 Aug; 24(8):1286-1297. PubMed ID: 35218667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
    Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
    Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
    Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
    J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment.
    Wu J; Guo J; Fang Q; Liu Y; Li C; Xie W; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1131693. PubMed ID: 37522128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular cells in pituitary neuroendocrine tumors.
    Delfin L; Mete O; Asa SL
    Hum Pathol; 2021 Aug; 114():1-8. PubMed ID: 33991528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
    García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
    Kara M; Tokat F; Pamir MN; Danyeli AE
    Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Profiling of Lactotroph Pituitary Neuroendocrine Tumors via RNA Sequencing and Ingenuity Pathway Analysis.
    Hattori Y; Tahara S; Ozawa H; Morita A; Ishii H
    Neuroendocrinology; 2024 Apr; ():. PubMed ID: 38643763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.